Navigation Links
Halozyme Reports Fourth Quarter and Year End 2012 Financial Results
Date:2/25/2013

meHalozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the Company's research focuses primarily on a family of human enzymes, known as hyaluronidases, which increase the absorption and dispersion of biologics, drugs and fluids. Halozyme's pipeline addresses therapeutic areas, including diabetes, oncology and dermatology that have significant unmet medical need. The Company markets Hylenex® recombinant (hyaluronidase human injection) and has partnerships with Roche, Pfizer, Baxter, ViroPharma and Intrexon. Halozyme is headquartered in San Diego, CA. For more information on how we are innovating, please visit our corporate website at www.halozyme.com.

Safe Harbor StatementIn addition to historical information, the statements set forth above include forward-looking statements (including, without limitation, statements concerning the Company's expected net cash burn for 2013, the development and commercialization of products and the potential benefits and attributes of such products) that involve risk and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. The forward-looking statements are also identified through use of the words "believe," "enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict," "probable," "potential," "possible," "should," "continue," and other words of similar meaning. Actual results could differ materially from the expectations contained in forward-looking statements as a result of several factors, including unexpected expenditures and costs, unexpected results or delays in development and regulatory review, regulatory approval requirements, unexpected adverse event and competi
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera
2. Halozyme Therapeutics To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
3. Halozyme to Host Third Quarter Financial Results Conference Call
4. Halozyme Reports Second Quarter 2012 Financial Results
5. Halozyme Confirms Baxter Has Received A Complete Response Letter For HyQ BLA
6. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
7. Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
8. Halozyme Reports First Quarter 2012 Financial Results
9. Halozyme to Host First Quarter 2012 Financial Results Conference Call
10. Novartis Reports Omalizumab Significantly Improved Chronic Idiopathic Urticaria Symptoms in Patients Who Failed Standard Therapy
11. Synthetic Biologics Reports that Flupirtine Sublicensee, Meda AB, to Initiate Phase II Fibromyalgia Clinical Trial in U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 4, 2015 Rogne Bioscience, a privately-held biotechnology ... that preclinical and mechanism of action data will be ... Investigative Dermatology (SID) Annual Meeting being held May 6-9, ... Georgia . Logo - http://photos.prnewswire.com/prnh/20150501/213318LOGO ... RON2315, a novel, low MW (<1700 daltons) peptide as ...
(Date:5/4/2015)... 2015  Oncobiologics, Inc., a biotherapeutics company focused ... has completed the construction of its GMP commercial ... Cranbury, New Jersey . ... designed to utilize multiple technologies that enable rapid ... the use of the latest single-use technologies, the ...
(Date:5/4/2015)... , May 4, 2015  By looking ... possible to distinguish between two very different conditions ... Theodore Henderson , MD, PhD., a ... complex cases, this study can help ... and therefore treatment options, for Post-Traumatic Stress Disorder ...
Breaking Medicine Technology:Rogne Bioscience to Present Data from Topical Biologic Psoriasis Program at Upcoming SID Annual Meeting 2015 2Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 2Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 3New Medical Research Shows Brain Imaging Can Now Help Doctors Differentiate Between PTSD and Traumatic Brain Injuries 2New Medical Research Shows Brain Imaging Can Now Help Doctors Differentiate Between PTSD and Traumatic Brain Injuries 3
... A new software technology is helping to reduce the ... identifying the sperm, eggs, resulting embryos and other materials ... cycles. Using non-invasive Radio Frequency Identification (RFID), IVF Witness(TM) ... the course of treatment. If the wrong material is ...
... 12 Nearly one in three adult Americans have triglyceride ... have low HDL "good" cholesterol levels. To help increase ... launched two Web sites: www.knowyourhdl.com and ... low HDL levels are factors that can raise the risk ...
Cached Medicine Technology:New Technology Reduces Risk of IVF Laboratory Mistakes by Electronically Identifying Sperm, Eggs and Other Materials for Each Patient 2New Technology Reduces Risk of IVF Laboratory Mistakes by Electronically Identifying Sperm, Eggs and Other Materials for Each Patient 3New Web Sites Educate About Triglycerides and HDL Cholesterol 2
(Date:5/4/2015)... Ticket Down is a reputable source for authentic ... in Charlottesville, VA. McCartney is one of the ... and this beloved performer continues to roll along with no ... two legendary groups: Wings and The Beatles, has been celebrating ... on the “Out There” tour and has continually added new ...
(Date:5/4/2015)... Chicago, Ill., (PRWEB) May 04, 2015 ... the American Brain Tumor Association (ABTA) show that people ... their diagnosis and treatment options, including clinical trials, at ... of days to make difficult decisions about their course ... the launch of the first nationwide brain tumor volunteer ...
(Date:5/4/2015)... Pricing Healthcare announces it will be paying ... care at St. George Surgical Center in the ... by July 15th, 2015, and the patient must be a ... forego the filing of insurance claims). , The healthcare system ... it devastates more and more individuals and families. Rising ...
(Date:5/4/2015)... 2015 Sheltering Arms announced that it ... House. The Mother Hale Learning Center meets a tremendous ... Education. Sheltering Arms will begin operating the site immediately ... by the center. , Opened in 2006, the Mother ... to five years, many of whom come from high-need ...
(Date:5/4/2015)... New West Medicare is excited to announce they ... outpatient advanced imaging services for its members. Care to ... are provided the right test at the right time ... West Medicare’s physicians and hospitals, Care to Care will ... and provide an objective basis for informed evidence-based clinical ...
Breaking Medicine News(10 mins):Health News:Paul McCartney Tickets at John Paul Jones Arena in Charlottesville, VA: Ticket Down Slashes Paul McCartney Ticket Prices in Charlottesville at the John Paul Jones Arena 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 3Health News:Sheltering Arms Acquires the Mother Hale Learning Center 2Health News:New West Medicare Partners with Care to Care, LLC to Manage Advanced Imaging Services 2
... Delhi: You do not need to make sudden changes in ... the latest buzzword in the field// of health sciences, can ... the genetic makeup of your body. ,Health expert Dr. ... that now one doesn't have to go through the depression ...
... has claimed 13 lives in barely one month in Malaysia ... ,Deputy Health Director-General Ramlee Rahma said five more dengue fever ... of this year, bringing the total death toll to 13 ... has reported 1,423 suspected cases, of which 403 have been ...
... Study Center has received a $3.5 million National Institute ... ongoing, multidisciplinary research program// on autism and related developmental ... on developmental aspects and outcomes for affected patients. The ... of autism in infants at risk for the condition, ...
... University of Michigan Medical School researchers report that a single ... body weight, response to insulin// and leptin, and energy balance. ... activity in brain cells were reported in the February issue ... it’s far too early to say how this protein could ...
... powerful British MPs, members of the Committee of Public Accounts, has ... obesity//. ,Levels of obesity in children aged two to ... 1995 and 2004, according to the Health Survey for England. ... now classed as obese. ,The Public Accounts Committee report ...
... As Britons’ average waistlines expand, so does the number of ... The British Association of Aesthetic Plastic Surgeons (BAAPS) gives ... operations carried out last year, as being liposuction ... ,The most popular ‘fixes’ include areas of the ...
Cached Medicine News:Health News:A Protein in Brain Cells Controls Obesity: Research 2Health News:A Protein in Brain Cells Controls Obesity: Research 3Health News:A Protein in Brain Cells Controls Obesity: Research 4Health News:Under-Elevens Hurtle Towards Obesity, British MPs Call for Action 2Health News:Liposuction, Quick Fixes for the Obese 2
... Fully automated chemiluminescence assay for ... hormone in serum. Growth Hormone ... secreted by the anterior pituitary ... hypothalamic growth hormone releasing hormone ...
... unique DHEA-S-7kits feature a ... against the C-7 position ... with no cross-reactivity with ... RIA has been optimized ...
Inquire...
Rapid latex slide agglutination assay for the qualitative and semi-quantitative determination of Rheumatoid Factors in human serum....
Medicine Products: